1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Atomoxetine restores the response inhibition network in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
(
- Contribution to journal › Article
-
Mark
A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment
(
- Contribution to journal › Article
- 2015
-
Mark
Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
(
- Contribution to journal › Article
-
Mark
Improving response inhibition in Parkinson's disease with atomoxetine
(
- Contribution to journal › Article
- 2014
-
Mark
Targeting impulsivity in Parkinson's disease using atomoxetine
(
- Contribution to journal › Article
-
Mark
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Characterizing mild cognitive impairment in incident Parkinson disease : the ICICLE-PD study
(
- Contribution to journal › Article
- 2013
-
Mark
The CamPaIGN study of Parkinson's disease : 10-year outlook in an incident population-based cohort
(
- Contribution to journal › Article